US EditionPublished • loading... • Updated
Helping Patients Who Don’t Respond to Common Bladder Cancer Treatment
Summary by The Billings Gazette
58 Articles
58 Articles
Farm Talk Newspaper+56 Reposted by 56 other sources
Helping Patients Who Don’t Respond to Common Bladder Cancer Treatment
(StatePoint) The bladder cancer treatment landscape is rapidly evolving, particularly for patients who don’t respond to bacillus Calmette–Guérin (BCG), the most common intravesical immunotherapy for early-stage bladder cancer.
·Parsons, United States
Read Full Article
A new drug delivery device has yielded impressive results: Completely eliminating bladder tumors in more than 80% of cancer patients who had failed to respond to previous treatments.
·Viet Nam
Read Full ArticleCoverage Details
Total News Sources58
Leaning Left7Leaning Right8Center22Last UpdatedBias Distribution59% Center
Bias Distribution
- 59% of the sources are Center
59% Center
L 19%
C 59%
R 22%
Factuality
To view factuality data please Upgrade to Premium
